Roles of NHERF1/EBP50 in cancer

被引：87

作者：

Georgescu, Maria-Magdalena ^{[1
]}

Morales, Fabiana C. ^{[1
]}

Molina, Jennifer R. ^{[1
]}

Hayashi, Yuho ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA

来源：

CURRENT MOLECULAR MEDICINE | 2008年 / 8卷 / 06期

关键词：

D O I：

10.2174/156652408785748031

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

This review summarizes the emerging roles of NHERF1/EBP50 adaptor protein in tumorigenesis. NHERF1/EBP50 ((N) under bara(+)/(H) under bar (+) (e) under bar xchanger (r) under bar egulating (f) under bar actor 1; ezrin-radixin-moesin ((E) under bar RM) (b) under bar inding (p) under bar hosphoprotein of 50 kDa) is a PDZ domain-containing protein with physiological localization at the plasma membrane. We discuss in this review the functions of NHERF1/EBP50 as a linker between membrane proteins and the cytoskeleton network, as well as its involvement in different types of cancer, such as breast and liver cancers. Recent evidence obtained from our laboratory and from other groups shows that NHERF1/EBP50 is an important player in cancer progression. It appears that, depending on its subcellular distribution, NHERF1/EBP50 may behave either as a tumor suppressor, when it is localized at the plasma membrane, or as an oncogenic protein, when it is shifted to the cytoplasm. We provide here an overview of the mechanisms by which this adaptor protein controls cell transformation, and propose a model suggesting a dual role of NHERF1/EBP50 in cancer.

引用

页码：459 / 468

页数：10

共 112 条

[91] Recognition of unique carboxyl-terminal motifs by distinct PDZ domains [J].

Songyang, Z ;

Fanning, AS ;

Fu, C ;

Xu, J ;

Marfatia, SM ;

Chishti, AH ;

Crompton, A ;

Chan, AC ;

Anderson, JM ;

Cantley, LC .

SCIENCE, 1997, 275 (5296) :73-77

[92] Repeated observation of breast tumor subtypes in independent gene expression data sets [J].

Sorlie, T ;

Tibshirani, R ;

Parker, J ;

Hastie, T ;

Marron, JS ;

Nobel, A ;

Deng, S ;

Johnsen, H ;

Pesich, R ;

Geisler, S ;

Demeter, J ;

Perou, CM ;

Lonning, PE ;

Brown, PO ;

Borresen-Dale, AL ;

Botstein, D .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (14) :8418-8423

[93] Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers [J].

Steck, PA ;

Pershouse, MA ;

Jasser, SA ;

Yung, WKA ;

Lin, H ;

Ligon, AH ;

Langford, LA ;

Baumgard, ML ;

Hattier, T ;

Davis, T ;

Frye, C ;

Hu, R ;

Swedlund, B ;

Teng, DHF ;

Tavtigian, SV .

NATURE GENETICS, 1997, 15 (04) :356-362

[94] NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas [J].

Stemmer-Rachamimov, AO ;

Wiederhold, T ;

Nielsen, GP ;

James, M ;

Pinney-Michalowski, D ;

Roy, JE ;

Cohen, WA ;

Ramesh, V ;

Louis, DN .

AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (01) :57-62

[95] PDZ domain binding selectivity is optimized across the mouse proteome [J].

Stiffler, Michael A. ;

Chen, Jiunn R. ;

Grantcharova, Viara P. ;

Lei, Ying ;

Fuchs, Daniel ;

Allen, John E. ;

Zaslavskaia, Lioudmila A. ;

MacBeath, Gavin .

SCIENCE, 2007, 317 (5836) :364-369

[96] PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling [J].

Takahashi, Y ;

Morales, FC ;

Kreimann, EL ;

Georgescu, MM .

EMBO JOURNAL, 2006, 25 (04) :910-920

[97] Na+/H+ exchanger regulatory factor-1 is a hematopoietic ligand for a subset of the CD34 family of stem cell surface proteins [J].

Tan, Poh C. ;

Furness, Sebastian G. B. ;

Merkens, Helen ;

Lin, Shujun ;

McCoy, Marcia L. ;

Roskelley, Calvin D. ;

Kast, Juergen ;

McNagny, Kelly M. .

STEM CELLS, 2006, 24 (05) :1150-1161

[98] Altered expression of the ERM proteins in lung adenocarcinoma [J].

Tokunou, M ;

Niki, T ;

Saitoh, Y ;

Imamura, H ;

Sakamoto, M ;

Hirohashi, S .

LABORATORY INVESTIGATION, 2000, 80 (11) :1643-1650

[99] A NOVEL MOESIN-LIKE, EZRIN-LIKE, RADIXIN-LIKE GENE IS A CANDIDATE FOR THE NEUROFIBROMATOSIS-2 TUMOR SUPPRESSOR [J].

TROFATTER, JA ;

MACCOLLIN, MM ;

RUTTER, JL ;

MURRELL, JR ;

DUYAO, MP ;

PARRY, DM ;

ELDRIDGE, R ;

KLEY, N ;

MENON, AG ;

PULASKI, K ;

HAASE, VH ;

AMBROSE, CM ;

MUNROE, D ;

BOVE, C ;

HAINES, JL ;

MARTUZA, RL ;

MACDONALD, ME ;

SEIZINGER, BR ;

SHORT, MP ;

BUCKLER, AJ ;

GUSELLA, JF .

CELL, 1993, 72 (05) :791-800

[100] ERM proteins: Head-to-tail regulation of actin-plasma membrane interaction [J].

Tsukita, S ;

Yonemura, S ;

Tsukita, S .

TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (02) :53-58

← 3 4 5 6 7 8 9 10 11 12 →